News

The University of Montpellier obtains new funding for its
NANOREMEDI project

] - Published on in Press room

Lhe project Functional Nano-Scaffolds for Regenerative Medicine, otherwise known as NANOREMEDIproject, led by Gilles Subra, professor at the Faculty of Pharmacy, and Cécile Echalier, teacher-researcher specializing in biomaterials chemistry at IBMM, with the participation of Danièle Noël's team at IRMB, has been awarded €565,000 in funding from the Marie Skłodowska-Curie Actions Doctoral Network for the training and research of doctoral students at the University of Montpellier.

The NANOREMEDI project in a nutshell

NANOREMEDI, which officially started on September1, 2022 and will run for 4 years, is a Marie Skłodowska-Curie Actions Doctoral Network project run by a consortium of 6 universities in Europe. The main objective is to train 13 PhD students in the field of peptides and nanomaterials. Each of them will be under joint supervision with 2 universities, and will spend the majority of their time at the recruiting university, 9 months at the second and 3 months at an industrial partner. In addition, these PhD students will benefit from cross-disciplinary training and will take part in international workshops organized by NANOREMEDI's partners. The University of Montpellier will therefore be recruiting two PhD students for this project, in cotutelle with the University of Milan (Italy) and IC Nanogune (San Sebastian, Spain), and will be receiving two others for a period of 9 months each, also in cotutelle with the University of Milan and the University of Jerusalem.

From a scientific point of view, the project aims to improve human health by addressing three major challenges:

  • Engineering vascular grafts to replace damaged arteries,
  • The development of stem cell-based biotherapies for bone and cartilage repair,
  • Developing strategies to facilitate implant integration and prevent bacterial contamination.

Funding for IBM and IRMB at the University of Montpellier

With the University of Montpellier, 5 other universities: University of Milano (Department of Pharmaceutical Sciences), Universitat Politècnica de Catalunya (Barcelona Tech Department of Chemical Engineering), The Hebrew University Jerusalem (Institute of Chemistry), University of Pavia (Department of Drug Sciences), IC NANOGUNE ("Self-Assembly" Group, - San Sebastian) as well as 11 industrial partners, including two from France (Lynxter and Genepep), are driving the NANOREMEDI project, which has received total funding of €3.4 million.

The UM has been awarded €565,000. This means that IBMM and IRMB have the means to finance consumables and equipment to support theses and organize workshops. These same Marie Skłodowska-Curie Actions Doctoral Network funds are used to set up doctoral programs in partnership with universities and companies from different sectors across Europe, with the aim of training highly qualified doctoral students, stimulating their creativity, strengthening their capacity for innovation and ensuring their long-term employability in Europe.  

Practical information:

The NANOREMEDI project in detail: https: //www.nanoremedi.eu/